Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Orchid Pharma Ltd. (ORCHPHARMA)
Market Closed
11 Aug, 10:00
XNSE
All
(3)
IN
(3)
XNSE
Primary
MSE
MSE
₹
1,101.
35
+22.2
+2.0572%
₹
26.97B
Market Cap
37.45
P/E Ratio
12%
Div Yield
32,814
Volume
0
Eps
₹
1,079.15
Previous Close
Watching
Watch
Add Transaction
Day Range
1,091.7
1,115
Year Range
480
1,119.8
Want to track
ORCHPHARMA
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Orchid Pharma Ltd. (ORCHPHARMA) Statistics
Valuation metrics
Market Cap
26.97B
Enterprise value
54.37B
Trailing P/E (ttm)
249.84
Forward P/E
19.5
PEG ratio
-3.14
Price/Sales (ttm)
6.26
Price/Book (mrq)
3.94
Enterprise Value/Revenue
6.7
Enterprise Value/EBITDA
87.92
Overview
Shares outstanding
50.72M
Float
15.28M
Shares short
-
% Held by insiders
0.7%
% Held by institutions
0.17%
Average volume (10 days)
39.24K
Average volume (90 days)
184.14K
Price summary
52-Week low
480
52-Week high
1,119.8
Beta
0.17
50-Day moving average
995.81
200-Day moving average
747.67
Dividends and splits
Forward annual dividend rate
12
Forward annual dividend yield
0.0239%
Trailing annual dividend rate
3
Trailing annual dividend yield
0.006%
5-Year annual dividend yield
3.01%
Payout ratio
-
Dividend Date
-
Ex-Dividend Date
-
Last split factor
1:218
Last split Date
25 Jul 2019
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.03%
Operating margin
0.05%
Operational effectiveness
Return on assets
0.01%
Return on equity
0.02%
Income Statement
Revenue (ttm)
8.11B
Revenue per share (ttm)
160.01
Quarterly revenue growth (yoy)
-0.05%
Gross profit (ttm)
2.76B
EBITDA
881.08M
Net income to common (ttm)
190.61M
Diluted EPS (ttm)
4.01
Quarterly earnings growth (yoy)
-0.05%
Balance Sheet
Total cash (mrq)
1.49B
Total cash per share (mrq)
16.58
Total debt (mrq)
2.82B
Total Debt/Equity (mrq)
0.28
Current ratio (mrq)
2.45%
Book value per share (mrq)
253.98
Cash Flow
Cash flow statement
-82.7M
Levered free cash flow (LFCF)
996.57M